Back
Prime Medicine Vs. ePlus Industry Stock Comparison
Sell
39
PRME
Prime Medicine
Last Price:
3.60
Seasonality Move:
-6.32%
Sell
27
PLUS
ePlus
Last Price:
80.50
Seasonality Move:
20.86%
Sell
39
Prime Medicine (PRME)
is a Sell
Is Prime Medicine a Buy, Sell or Hold?
- The current Prime Medicine [PRME] share price is $3.96. The Score for PRME is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- PRME is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ePlus (PLUS)
is a Sell
Is ePlus a Buy, Sell or Hold?
- The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRME Stock Price Chart
What is Prime Medicine's stock price today?
-
The Prime Medicine share price today is $3.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRME is experiencing selling pressure, which indicates risk of future bearish movement.
PLUS Stock Price Chart
PRME Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 47.8 | Sell |
Chaikin Money Flow: | -1483520 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.8 - 4.28) | Sell |
Bollinger Bands (100): | (3.67 - 5.25) | Sell |
PLUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.37 | Sell |
Relative Strength Index (14 RSI): | 28.12 | Sell |
Chaikin Money Flow: | -371573 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.15 - 100.85) | Sell |
Bollinger Bands (100): | (81.19 - 98.29) | Sell |
PRME Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.14 | Sell |
20-day SMA: | 4.14 | Sell |
50-day SMA: | 3.89 | Buy |
200-day SMA: | 5.59 | Sell |
8-day EMA: | 4.14 | Sell |
20-day EMA: | 4.07 | Sell |
50-day EMA: | 4.11 | Sell |
200-day EMA: | 5.71 | Sell |
PLUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 93.25 | Sell |
20-day SMA: | 94.97 | Sell |
50-day SMA: | 95.27 | Sell |
200-day SMA: | 83.59 | Sell |
8-day EMA: | 92.26 | Sell |
20-day EMA: | 94.28 | Sell |
50-day EMA: | 94.05 | Sell |
200-day EMA: | 84.44 | Sell |
Prime Medicine Earnings Growth & PRME Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.27 per share.
ePlus Earnings Growth & PLUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.
Prime Medicine Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ePlus Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |